Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ZIVO Bioscience, Inc. (ZIVO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.7076+0.1476 (+5.77%)
At close: 11:04AM EST
2.6800 -0.03 (-1.02%)
After hours: 05:59PM EST
Advertisement

ZIVO Bioscience, Inc.

21 East Long Lake Road
Suite 100
Bloomfield Hills, MI 48304
United States
248 452 9866
https://www.zivobioscience.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees10

Key Executives

NameTitlePayExercisedYear Born
Mr. John B. PaynePres, CEO & Chairman39.55kN/A1948
Mr. Keith R. MarchiandoCFO, Treasurer & Sec.414.58kN/A1962
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.

Corporate Governance

ZIVO Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement